Royal Bank Of Canada Issues Pessimistic Forecast for Ardent Health (NYSE:ARDT) Stock Price

Ardent Health (NYSE:ARDT) had its target price cut by Royal Bank Of Canada from $13.00 to $12.00 in a report issued on Thursday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Royal Bank Of Canada’s price target would suggest a potential upside of 18.85% from the stock’s current price.

Other research analysts also recently issued reports about the company. Zacks Research upgraded Ardent Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 25th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Ardent Health in a research report on Friday, June 12th. Wall Street Zen raised shares of Ardent Health from a “hold” rating to a “buy” rating in a report on Saturday, May 16th. Finally, UBS Group upped their target price on shares of Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Seven investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $14.12.

Ardent Health Price Performance

NYSE:ARDT opened at $10.10 on Thursday. The company has a quick ratio of 2.00, a current ratio of 2.12 and a debt-to-equity ratio of 0.62. The business’s 50-day simple moving average is $9.60 and its two-hundred day simple moving average is $9.25. The stock has a market cap of $1.45 billion, a PE ratio of 10.63, a P/E/G ratio of 2.28 and a beta of 0.76. Ardent Health has a 52 week low of $7.71 and a 52 week high of $15.48.

Ardent Health (NYSE:ARDT) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.18 by $0.10. Ardent Health had a return on equity of 13.85% and a net margin of 2.09%.The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.58 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. As a group, analysts forecast that Ardent Health will post 1.11 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CFO Alfred Lumsdaine purchased 10,000 shares of the business’s stock in a transaction on Friday, June 5th. The stock was acquired at an average price of $8.81 per share, for a total transaction of $88,100.00. Following the acquisition, the chief financial officer directly owned 329,183 shares of the company’s stock, valued at $2,900,102.23. This represents a 3.13% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.90% of the company’s stock.

Institutional Trading of Ardent Health

Several hedge funds have recently modified their holdings of ARDT. The Manufacturers Life Insurance Company increased its position in Ardent Health by 3.7% in the first quarter. The Manufacturers Life Insurance Company now owns 29,812 shares of the company’s stock worth $255,000 after purchasing an additional 1,072 shares during the last quarter. Geode Capital Management LLC increased its position in Ardent Health by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock valued at $3,918,000 after buying an additional 1,769 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its stake in Ardent Health by 1,177.7% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock valued at $25,000 after buying an additional 2,638 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in Ardent Health by 24.8% in the third quarter. Alliancebernstein L.P. now owns 16,472 shares of the company’s stock worth $218,000 after acquiring an additional 3,272 shares in the last quarter. Finally, New York State Common Retirement Fund grew its stake in shares of Ardent Health by 121.4% during the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock worth $85,000 after acquiring an additional 3,400 shares during the last quarter.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.